Remedium and Exothera partner on scale-up of gene therapy for osteoarthritis 27-Mar-2023 By Jane Byrne Remedium Bio, a US biotech, and Exothera, a Belgian CDMO, have established a collaborative agreement in relation to the US firm’s disease modifying gene therapy for osteoarthritis, AAV2-FGF18.